Potter NT[au] - Search Results

Year	Number of Results
1981	1
1985	1
1986	5
1987	2
1988	2
1989	1
1992	2
1994	1
1995	2
1996	4
1997	3
1998	1
1999	3
2000	2
2001	1
2003	1
2004	2
2009	1
2011	1
2014	2
2016	1
2022	0

1

Colorectal Cancer Screening Recommendations.

Mergener K, Potter NT. Mergener K, et al. Among authors: potter nt. JAMA. 2016 Oct 25;316(16):1716. doi: 10.1001/jama.2016.14915. JAMA. 2016. PMID: 27784087 No abstract available.

2

Monoclonal and polyclonal antibodies to myelin basic protein determinants.

Day ED, Potter NT. Day ED, et al. Among authors: potter nt. J Neuroimmunol. 1986 Feb;10(4):289-312. doi: 10.1016/S0165-5728(86)90014-7. J Neuroimmunol. 1986. PMID: 2418054 Review.

3

Sporadic ALS and chromosome 22: evidence for a possible neurofilament gene defect.

Meyer MA, Potter NT. Meyer MA, et al. Among authors: potter nt. Muscle Nerve. 1995 May;18(5):536-9. doi: 10.1002/mus.880180510. Muscle Nerve. 1995. PMID: 7739642 Review.

4

Neurogenetics in developmental and behavioral pediatrics: advances in molecular diagnosis.

Potter NT, Tarleton J. Potter NT, et al. J Dev Behav Pediatr. 1998 Apr;19(2):117-30. doi: 10.1097/00004703-199804000-00010. J Dev Behav Pediatr. 1998. PMID: 9584942 Review.

5

Technical standards and guidelines for Huntington disease testing.

Potter NT, Spector EB, Prior TW. Potter NT, et al. Genet Med. 2004 Jan-Feb;6(1):61-5. doi: 10.1097/01.gim.0000106165.74751.15. Genet Med. 2004. PMID: 14726813

6

Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study.

Johnson DA, Barclay RL, Mergener K, Weiss G, König T, Beck J, Potter NT. Johnson DA, et al. Among authors: potter nt. PLoS One. 2014 Jun 5;9(6):e98238. doi: 10.1371/journal.pone.0098238. eCollection 2014. PLoS One. 2014. PMID: 24901436 Free PMC article.

7

Rate of detection of high-risk HPV with two assays in women ≥ 30 years of age.

Quigley NB, Potter NT, Chivukula M, Knight MZ, Welch JR, Olson MC. Quigley NB, et al. Among authors: potter nt. J Clin Virol. 2011 Sep;52(1):23-7. doi: 10.1016/j.jcv.2011.05.014. Epub 2011 Jul 2. J Clin Virol. 2011. PMID: 21724457

8

Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.

Potter NT, Hurban P, White MN, Whitlock KD, Lofton-Day CE, Tetzner R, Koenig T, Quigley NB, Weiss G. Potter NT, et al. Clin Chem. 2014 Sep;60(9):1183-91. doi: 10.1373/clinchem.2013.221044. Epub 2014 Jun 17. Clin Chem. 2014. PMID: 24938752

9

You can build it ... but will they come?: the potential "expansion" of testing methodologies for fragile X syndrome.

Potter NT. Potter NT. J Mol Diagn. 2009 Jul;11(4):279-80. doi: 10.2353/jmoldx.2009.090047. Epub 2009 May 21. J Mol Diagn. 2009. PMID: 19460939 Free PMC article.

10

Molecular and clinical findings in a family with dentatorubral-pallidoluysian atrophy.

Potter NT, Meyer MA, Zimmerman AW, Eisenstadt ML, Anderson IJ. Potter NT, et al. Ann Neurol. 1995 Feb;37(2):273-7. doi: 10.1002/ana.410370220. Ann Neurol. 1995. PMID: 7847869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results